Denise P. Carter - Net Worth and Insider Trading

Denise P. Carter Net Worth

The estimated net worth of Denise P. Carter is at least $25,901 dollars as of 2024-09-20. Denise P. Carter is the COO of Quoin Pharmaceuticals Ltd and owns about 47,092 shares of Quoin Pharmaceuticals Ltd (QNRX) stock worth over $25,901. Details can be seen in Denise P. Carter's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Denise P. Carter has not made any transactions after 2024-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Denise P. Carter

To

Denise P. Carter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Denise P. Carter owns 1 companies in total, including Quoin Pharmaceuticals Ltd (QNRX) .

Click here to see the complete history of Denise P. Carter’s form 4 insider trades.

Insider Ownership Summary of Denise P. Carter

Ticker Comapny Transaction Date Type of Owner
QNRX Quoin Pharmaceuticals Ltd 2024-09-04 director & Chief Operating Officer

Denise P. Carter Latest Holdings Summary

Denise P. Carter currently owns a total of 1 stock. Denise P. Carter owns 47,092 shares of Quoin Pharmaceuticals Ltd (QNRX) as of September 4, 2024, with a value of $25,901.

Latest Holdings of Denise P. Carter

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QNRX Quoin Pharmaceuticals Ltd 2024-09-04 47,092 0.55 25,901

Holding Weightings of Denise P. Carter


Denise P. Carter Form 4 Trading Tracker

According to the SEC Form 4 filings, Denise P. Carter has made a total of 1 transactions in Quoin Pharmaceuticals Ltd (QNRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Quoin Pharmaceuticals Ltd is the acquisition of 37,735 shares on September 4, 2024, which cost Denise P. Carter around $28,679.

Insider Trading History of Denise P. Carter

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Denise P. Carter Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Denise P. Carter Ownership Network

Ownership Network List of Denise P. Carter

No Data

Ownership Network Relation of Denise P. Carter

Insider Network Chart

Denise P. Carter Owned Company Details

What does Quoin Pharmaceuticals Ltd do?

Who are the key executives at Quoin Pharmaceuticals Ltd?

Denise P. Carter is the director & Chief Operating Officer of Quoin Pharmaceuticals Ltd. Other key executives at Quoin Pharmaceuticals Ltd include Chief Financial Officer Gordon Dunn , and director & Chief Executive Officer Michael Myers .

Quoin Pharmaceuticals Ltd (QNRX) Insider Trades Summary

Over the past 18 months, Denise P. Carter made 1 insider transaction in Quoin Pharmaceuticals Ltd (QNRX) with a net purchase of 37,735. Other recent insider transactions involving Quoin Pharmaceuticals Ltd (QNRX) include a net purchase of 37,894 shares made by Michael Myers , a net purchase of 28,856 shares made by Gordon Dunn , and a net sale of 297 shares made by Dennis Langer .

In summary, during the past 3 months, insiders sold 0 shares of Quoin Pharmaceuticals Ltd (QNRX) in total and bought 104,485 shares, with a net purchase of 104,485 shares. During the past 18 months, 297 shares of Quoin Pharmaceuticals Ltd (QNRX) were sold and 104,485 shares were bought by its insiders, resulting in a net purchase of 104,188 shares.

Quoin Pharmaceuticals Ltd (QNRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Quoin Pharmaceuticals Ltd Insider Transactions

No Available Data

Denise P. Carter Mailing Address

Above is the net worth, insider trading, and ownership report for Denise P. Carter. You might contact Denise P. Carter via mailing address: Azrieli Center, Round Tower, 30th Floor, Tel Aviv L3 9701101.

Discussions on Denise P. Carter

No discussions yet.